U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
103141103141Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate CancerCompletedNo Results AvailableHormone Refractory Prostate CancerDrug: Bafetinibhttps://ClinicalTrials.gov/show/NCT01215799
103142103142Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedHas ResultsGlaucoma, Open-Angle|Ocular HypertensionDrug: AGN-207281 ophthalmic solutions (0.1% and 0.3%); AGN-207281 vehicle ophthalmic solution (placebo)|Drug: timolol ophthalmic solution 0.5%|Drug: AGN-207281 vehicle ophthalmic solution (Placebo)https://ClinicalTrials.gov/show/NCT01215786
103143103143Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.CompletedNo Results AvailableHealthyDrug: Placebo|Drug: BI 671800|Drug: BI 671800https://ClinicalTrials.gov/show/NCT01215773
103144103144Sensory Reeducation in Peripheral Nerve Injuries of HandCompletedNo Results AvailableMedian Nerve Disease|Ulnar Nerve Disease|Peripheral Nerve DiseaseOther: Training with a mirror|Other: No mirror therapyhttps://ClinicalTrials.gov/show/NCT01215760
103145103145Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA AmyloidosisActive, not recruitingNo Results AvailableAmyloidosisDrug: KIACTA (eprodisate disodium)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01215747
103146103146Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) RecipientsCompletedHas ResultsAdult Stem Cell Hematopoetic TransplantBiological: High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV)|Biological: Standard Dose Trivalent Inactivated Flu Vaccinehttps://ClinicalTrials.gov/show/NCT01215734
103147103147Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)CompletedHas ResultsUrinary IncontinenceDrug: Vesicarehttps://ClinicalTrials.gov/show/NCT01215721
103148103148Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal CalculusActive, not recruitingNo Results AvailableRenal CalculiDrug: Tamsulosinhttps://ClinicalTrials.gov/show/NCT01215708
103149103149Video-laryngoscope With a Novel Video-stylet for Difficult IntubationRecruitingNo Results AvailableDifficult Endotracheal IntubationDevice: aScope (Ambu Inc. 6740 Baymeadow Drive Glen Burnie, MD)|Device: Controlhttps://ClinicalTrials.gov/show/NCT01215695
103150103150Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent SwimmersCompletedNo Results AvailableUpper Respiratory Tract InfectionsDietary Supplement: vitamin D|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT01215682
103151103151Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in KoreaCompletedNo Results AvailableInfluenzaBiological: IDflu™: Split virion inactivated influenza vaccine|Biological: Vaxigrip®: Split virion inactivated influenza vaccine|Biological: IDflu™: Split virion inactivated influenza vaccine|Biological: Vaxigrip®: Split virion inactivated influenza vaccinehttps://ClinicalTrials.gov/show/NCT01215669
103152103152Effect of a Follow on Formula With Lactobacillus Fermentum on the Incidence of InfectionsCompletedNo Results AvailableIncidence of Infectious DiseasesDietary Supplement: Lactobacillus fermentum|Dietary Supplement: Follow on formula without probioticshttps://ClinicalTrials.gov/show/NCT01215656
103153103153Efficacy and Safety of DEB025 Alone or Combined With Either Ribavirin or Peg-IFN α2a in Chronic Hepatitis C Genotype 2 and 3 naïve PatientsCompletedNo Results AvailableHepatitis C|Chronic PainDrug: DEB025 1000 mg QD|Drug: DEB025 600 mg QD + RBV 400 mg BID|Drug: DEB025 800 mg QD + RBV 400 mg BID|Drug: DEB025 600 mg QD + peg-IFNα2a once weekly|Drug: SOC (peg-IFNα2a once weekly + RBV 400 mg BID)https://ClinicalTrials.gov/show/NCT01215643
103154103154Cardiovascular Fitness and Venous Function in Trained and Untrained SubjectsCompletedNo Results AvailableHealthy SubjectsBehavioral: Aerobic Interval Traininghttps://ClinicalTrials.gov/show/NCT01215630
103155103155The Effect of Aerobic Interval Training on Obstructive Sleep ApneaCompletedNo Results AvailableObstructive Sleep Apnea SyndromeBehavioral: Aerobic Interval training|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT01215617
103156103156Involvement of Translation Initiation Factors in the Immune Response in the ElderlyRecruitingNo Results AvailableElderly Patient|Infectionhttps://ClinicalTrials.gov/show/NCT01215604
103157103157Trial of Weaning of Nasal Continuous Positive Airway Pressure (CPAP)CompletedNo Results AvailablePreterm NeonatesProcedure: Gradual weaning from Nasal CPAP in preterm neonateshttps://ClinicalTrials.gov/show/NCT01215591
103158103158Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTerminatedNo Results AvailableNeuroendocrine Tumors|Pancreatic Neoplasms|Advanced Disease|SunitinibDrug: Sutenthttps://ClinicalTrials.gov/show/NCT01215578
103159103159Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNo Results AvailableHepatocellular Carcinoma|Fibrolamellar Hepatocellular CarcinomaDrug: Sutenthttps://ClinicalTrials.gov/show/NCT01215565
103160103160Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712TerminatedNo Results AvailableHealthy Elderly VolunteersDrug: HT-0712https://ClinicalTrials.gov/show/NCT01215552
103161103161Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer PatientsCompletedNo Results AvailableColorectal CancerDrug: panitumumabhttps://ClinicalTrials.gov/show/NCT01215539
103162103162A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerCompletedNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT01215526
103163103163Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean PatientsCompletedHas ResultsProstate CancerDrug: Degarelixhttps://ClinicalTrials.gov/show/NCT01215513
103164103164Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic CancerActive, not recruitingNo Results AvailableTumor|Cancer|Melanoma|Sarcoma|CarcinomaRadiation: Hypofractionated RThttps://ClinicalTrials.gov/show/NCT01215500
103165103165A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With ImatinibRecruitingNo Results AvailableChronic Myeloid LeukemiaProcedure: Stem Cell and Mutational Assayhttps://ClinicalTrials.gov/show/NCT01215487
103166103166Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLCCompletedNo Results AvailableMutations in Exons 18 to 21https://ClinicalTrials.gov/show/NCT01215474
103167103167Factors Associated With Mortality in NeonatesCompletedNo Results AvailableNeonatal Mortalityhttps://ClinicalTrials.gov/show/NCT01215461
103168103168Wheatgrass Juice / Lifestyle Recommendations / Cancer Patients' Quality of Life / Chemotherapy TreatmentCompletedNo Results AvailableFatigueDietary Supplement: Wheatgrass juicehttps://ClinicalTrials.gov/show/NCT01215448
103169103169Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCompletedHas ResultsDiabetes|Diabetes Mellitus, Type 2Drug: biphasic insulin aspart 30|Drug: biphasic insulin aspart 30https://ClinicalTrials.gov/show/NCT01215435
103170103170Success of Pediatric Anesthesiologists in Learning to Use VideolaryngoscopesCompletedHas ResultsTracheal Intubation MorbidityProcedure: timed intubationhttps://ClinicalTrials.gov/show/NCT01215422

* Görseller ve İçerik tekif hakkına sahip olabilir